We have previously described the use of the pro-Th2 cytokine, TSLP, as a nasal adjuvant [32] and hypothesized that the absence of pro-inflammatory T cells at mucosal sites may be advantageous as they can act as targets for HIV infection. This evidence concerns the gene TSLP and HIV infectious disease.